Allemang Brooke, Miatello Ashleigh, Maini Pranshu, Eszczuk Joshua, Tersigni Claudia, Micsinszki Samantha, Dave Sneha, Bollegala Natasha, Fu Nancy, Lee Kate, Anthony Samantha J, Barwick Melanie, Benchimol Eric I
Child Health Evaluative Sciences, SickKids Research Institute, The Hospital for Sick Children, Toronto, Canada.
Office of Patient, Family, and Community Engagement, The Hospital for Sick Children, Toronto, Canada.
Health Care Transit. 2025 Jul 5;3:100111. doi: 10.1016/j.hctj.2025.100111. eCollection 2025.
Patient engagement allows for developing health interventions and research studies that align with the needs of people living with chronic diseases. Actively involving people with lived experience as partners in the design and governance of interventional trials is gaining prominence. However, there is a dearth of literature exploring the processes and procedures of patient partnership in various stages of randomized controlled trials (RCTs) with adolescents and young adults (AYAs) with inflammatory bowel disease (IBD), specifically.
This reflective viewpoint outlines how AYA patient partners were involved in a RCT of an intervention to optimize transition from pediatric to adult care in IBD through a Youth Advisory Panel. To achieve this objective, we: i) gathered information from eight members of the study team via virtual discussions, ii) reflected on our experiences collaborating with patient partners in the RCT, and iii) reviewed relevant documents, including meeting minutes. Discussion transcripts, reflections, and documents were reviewed by two academic researchers and one AYA patient partner to identify the varying levels of involvement among AYA patient partners in the trial. The engagement strategies implemented to maximize the translational impact of the multimodal intervention and inform patient-centered care across various stages of the RCT were also examined.
The processes, outputs and impacts of AYAs' contributions in priority setting and planning, intervention design and refinement, study execution, dissemination, and post-trial intervention implementation and dissemination were identified. AYA patient partner motivations for involvement in the RCT and key learnings from this partnership were uncovered.
AYA patient partners' contributions to the RCT were impactful, from study conceptualization to dissemination. Their involvement ensured the intervention's relevance, usability, and youth-friendliness, informed data analysis, and enhanced knowledge translation through co-creation. Future work in this field could involve evaluating the impact of patient engagement on AYA patient partners, research teams, and research outcomes in RCTs.
患者参与有助于制定符合慢性病患者需求的健康干预措施和研究。让有实际经验的人作为合作伙伴积极参与干预性试验的设计和管理正变得越来越重要。然而,具体而言,缺乏关于炎症性肠病(IBD)青少年和青年(AYA)在随机对照试验(RCT)各阶段患者合作的流程和程序的文献。
本反思性观点概述了AYA患者合作伙伴如何通过青年咨询小组参与一项RCT,该试验旨在优化IBD患者从儿科到成人护理的过渡。为实现这一目标,我们:i)通过虚拟讨论从八名研究团队成员那里收集信息,ii)反思我们在RCT中与患者合作伙伴合作的经验,iii)审查相关文件,包括会议记录。两名学术研究人员和一名AYA患者合作伙伴审查了讨论记录、反思和文件,以确定AYA患者合作伙伴在试验中的不同参与程度。还研究了为最大限度地提高多模式干预的转化影响并为RCT各阶段以患者为中心的护理提供信息而实施的参与策略。
确定了AYA在优先事项设定和规划、干预设计和完善、研究执行、传播以及试验后干预实施和传播方面的贡献的过程、产出和影响。揭示了AYA患者合作伙伴参与RCT的动机以及从这种合作关系中获得的关键经验教训。
从研究概念化到传播,AYA患者合作伙伴对RCT的贡献是有影响力的。他们的参与确保了干预措施的相关性、可用性和对青年的友好性,为数据分析提供了信息,并通过共同创造增强了知识转化。该领域未来的工作可能包括评估患者参与对AYA患者合作伙伴、研究团队和RCT研究结果的影响。